These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 33516439

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM, Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC.
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [Abstract] [Full Text] [Related]

  • 3. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
    Casey DL, Wexler LH, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2019 Apr 01; 103(5):1151-1157. PubMed ID: 30508617
    [Abstract] [Full Text] [Related]

  • 4. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma.
    Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC.
    Radiother Oncol; 2019 May 01; 134():143-150. PubMed ID: 31005208
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
    Wolden SL, Lyden ER, Arndt CA, Hawkins DS, Anderson JR, Rodeberg DA, Morris CD, Donaldson SS.
    Int J Radiat Oncol Biol Phys; 2015 Dec 01; 93(5):1071-6. PubMed ID: 26581144
    [Abstract] [Full Text] [Related]

  • 9. Regional Nodal Control for Head and Neck Alveolar Rhabdomyosarcoma.
    Ludmir EB, Paulino AC, Grosshans DR, McAleer MF, McGovern SL, Huh WW, Okcu MF, Harrell LM, Mahajan A.
    Int J Radiat Oncol Biol Phys; 2018 May 01; 101(1):169-176. PubMed ID: 29477293
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy.
    Ladra MM, Mandeville HC, Niemierko A, Padera TP, Friedmann AM, MacDonald SM, Ebb D, Chen YL, Tarbell NJ, Yock TI.
    Int J Radiat Oncol Biol Phys; 2015 Jun 01; 92(2):358-67. PubMed ID: 25864172
    [Abstract] [Full Text] [Related]

  • 12. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
    Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA.
    Acta Oncol; 2019 Oct 01; 58(10):1404-1409. PubMed ID: 31530120
    [Abstract] [Full Text] [Related]

  • 13. Patterns of failure for rhabdomyosarcoma of the perineal and perianal region.
    Casey DL, Wexler LH, LaQuaglia MP, Meyers PA, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2014 May 01; 89(1):82-7. PubMed ID: 24725692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N, Duan C, Jin M, Zhang DW, Su Y, Yu T, He LJ, Fu LB, Zeng Q, Wang HM, Zhang WP, Ni X, Ma XL.
    Zhonghua Er Ke Za Zhi; 2019 Oct 02; 57(10):767-773. PubMed ID: 31594063
    [Abstract] [Full Text] [Related]

  • 16. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
    Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A, European paediatric Soft tissue sarcoma Study Group.
    Lancet Oncol; 2019 Nov 02; 20(11):1566-1575. PubMed ID: 31562043
    [Abstract] [Full Text] [Related]

  • 17. Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography.
    Casey DL, Wexler LH, Fox JJ, Dharmarajan KV, Schoder H, Price AN, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2014 Dec 01; 90(5):1136-42. PubMed ID: 25539372
    [Abstract] [Full Text] [Related]

  • 18. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
    Douglas JG, Arndt CA, Hawkins DS.
    Eur J Cancer; 2007 Apr 01; 43(6):1045-50. PubMed ID: 17368885
    [Abstract] [Full Text] [Related]

  • 19. The challenging role of radiation therapy for very young children with rhabdomyosarcoma.
    Puri DR, Wexler LH, Meyers PA, La Quaglia MP, Healey JH, Wolden SL.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1177-84. PubMed ID: 16682130
    [Abstract] [Full Text] [Related]

  • 20. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Chargari C, Haie-Meder C, Guérin F, Minard-Colin V, de Lambert G, Mazeron R, Escande A, Marsolat F, Dumas I, Deutsch E, Valteau-Couanet D, Audry G, Oberlin O, Martelli H.
    Int J Radiat Oncol Biol Phys; 2017 Jun 01; 98(2):352-359. PubMed ID: 28463154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.